Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 26, 19-33, February 1, 1966]
© 1966 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davis, A. P.
Right arrow Articles by Shimkin, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davis, A. P.
Right arrow Articles by Shimkin, M. B.

Response of Wistar Rats with Breast Cancer Induced by 3-Methylcholanthrene to Thirty-One Compounds1

A. P. Davis, L. Gropper and M. B. Shimkin

( Fels Research Institute, Temple University School of Medicine, Philadelphia, Pennsylvania)

Twenty-three nonhormonal and 8 hormonal agents were tested for antineoplastic activity against mammary carcinoma induced by gastric instillations of 3-methylcholanthrene (NSC-21970) in female Wistar rats. Three nonhormonal agents were active: NSC-185 (actidione), NSC-26980 (mitomycin C), NSC-37095 (AB-100); 4 hormonal agents were active: NSC-741 (hydrocortisone acetate), NSC-3070 (diethylstilbestrol), NSC-9566 (17ß-estradiol, 3-benzoate), and NSC-12198 (4,5{alpha}-dihydro-2{alpha}-methyltestosterone propionate). The results were compared with results, reported by other investigators, of testing the agents against Adenocarcinoma 755, a transplanted mouse tumor.

1 Supported by contract SA-43-ph-4344 from the Cancer Chemotherapy National Service Center, National Cancer Institute, National Institutes of Health, Public Health Service.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1966 by the American Association for Cancer Research.